Abstract
Sensory system examination is a very important part of clinical neurology. Quantitative sensory studies using automated systems to evaluate the sensory function are useful in clinical and experimental studies of peripheral neuropathies. This chapter discusses the sensory receptors, sensory examination, and a quantitative system designed to deliver sensory stimuli, including touch-pressure, vibration, thermal, and heat-pain sensory stimuli, in a quantifiable and reproducible manner.
Keywords
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Lawson SN. The peripheral sensory nervous system: dorsal root ganglion neurons. In: Dyck PJ, Thomas PK, editors. Peripheral neuropathy. 4th ed. Philadelphia: Elsevier Saunders; 2005. p. 163–202.
Kandel ER, Schwartz JH, Jessell TM, editors. The bodily senses. In: Principles of neural sciences. 4th ed. New York: McGraw Hill; 2000, p. 430–50.
Pestronk A, Florence J, Levine T, Al-Lozi MT, Lopate G, Miller T, et al. Sensory exam with quantitative tuning fork: rapid, sensitive and predictive of SNAP amplitude. Neurology. 2004;62:461–4.
Dyck PJ, O’Brien P, Johnson D, Klein C, Dyck PJB. Quantitative sensory testing. In: Dyck PJ, Thomas PK, editors. Peripheral neuropathy. 4th ed. Philadelphia: Elsevier-Saunders; 2005. p. 1063–94.
Lowenstein DH, Martin JB, Hauser SL. Approach to the patient with neurologic disease. In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, et al., editors. Harrison’s principles of internal medicine. 17th ed. New York: McGraw-Hill; 2008. p. 2484–9.
Martina I, van Koningsveld R, Schmitz P, van der Meche F, van Doorn P. For the European Inflammatory Neuropathy Cause and Treatment (INCAT) Group. Measuring vibration threshold with a graduated tuning fork in normal aging and in patients with polyneuropathy. J Neurol Neurosurg Psychiatry. 1998;65:743–7.
Weinstein S. Fifty years of somatosensory research: from the Semmes-Weinstein monofilaments to the Weinstein Enhanced Sensory Test. J Hand Ther. 1993;6:11–22.
Mayfield J, Sugarman J. The use of the Semmes-Weinstein monofilament and other threshold tests for preventing foot ulceration and amputation in persons with diabetes. J Fam Pract. 2000;49(suppl):S17–29.
Olaleye D, Perkins B, Bril V. Evaluation of three screening tests and a risk assessment model for diagnosing peripheral neuropathy in the diabetes clinic. Diabetes Res Clin Pract. 2001;54:115–28.
Burns T, Taly A, O’Brien P, Dyck PJ. Clinical versus quantitative assessment improving clinical performance. J Peripher Nerv Syst. 2002;7:112–7.
Perkins B, Olaleye D, Zinman B, Bril V. Simple screening tests for peripheral neuropathy in the diabetic clinic. Diabetes Care. 2001;24:250–6.
Mythili A, Kumar K, Subrahmanyam K, Venkateswarlu K, Butchi R. A comparative study of examination scores and quantitative sensory testing in diagnosis of diabetic polyneuropathy. Int J Diabetes Dev Ctries. 2010;30:43–8.
Dyck PJ, Zimmermann I, O’Brien PC, Ness A, Caskey P, Karnes J, et al. Introduction of automated systems to evaluate touch-pressure, vibration, and thermal cutaneous sensation in man. Ann Neurol. 1978;4:502–10.
Tick Chong PS, Cros DP. Technology literature review: quantitative sensory testing. Muscle Nerve. 2004;29:734–47.
Freeman R, Stewart JD. Quantitative sensory testing. In: Katirji B, Preston E, Kaminski H, Shapiro B, Ruff R, editors. Neuromuscular disorders in clinical practice. Philadelphia: Elsevier; 2001. p. 183–92.
Verdugo R, Ochoa J. Quantitative sensory testing: a key method for functional evaluation of small calibre afferent channels. Brain. 1992;115:893–913.
Reulen JPH, Lansbergen MDI, Verstraete E, Spaans F. Comparison of thermal threshold tests to assess small nerve fiber function: limits vs. levels. Clin Neurophysiol. 2003;114:556–63.
Yarnitsky D, Sprecher E. Thermal testing: normative data and repeatability for various test algorithms. J Neurol Sci. 1994;125:39–45.
Dyck PJ, Karnes JL, Gillen DA, O’Brien PC, Zimmermann IR, Johnson DM. Comparison of algorithms of testing for use in automated evaluation of sensation. Neurology. 1990;40:1607–13.
Dyck PJ, Zimmermann I, Gillen DA, Johnson D, Karnes JL, O’Brien PC. Cool, warm and heat-pain detection thresholds: testing methods and inferences about anatomic distribution of receptors. Neurology. 1993;43:1500–8.
Gruener G, Dyck PJ. Quantitative sensory testing: methodology, applications and future directions. J Clin Neurophysiol. 1994;11:568–83.
Dyck PJ, O’Brien PC, Kosanke JL, Gillen DA, Karnes JL. A 4,2, and 1 stepping algorithm for quick and accurate estimation of cutaneous sensation threshold. Neurology. 1993;43:1508–12.
Kandel ER, Schwartz JH, Jessell TM, editors. Coding of sensory information. In: Principles of neural sciences. 4th ed. New York: McGraw Hill; 2000, p. 411–29.
Carterette EC. A computer program for estimating thresholds by means of Wetherill’s Up-Down Transformed Response Rule (UDTR). J Aud Res. 1984;24:191–204.
Dyck PJ, Zimmermann IR, Johnson DM, Gillen D, Hokanson J, Karnes JL, et al. A standard test of heat-pain responses by CASE IV. J Neurol Sci. 1996;136:54–63.
Dyck PJ, O’Brien PC, Litchy WJ, Harper CM, Daube JR, Dyck PJB. Use of percentiles and normal deviates to express nerve conduction and other test abnormalities. Muscle Nerve. 2001;24:307–10.
Rolke R, Baron R, Maier C, Tolle TR, Treede R, Beyer A, et al. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values. Pain. 2006;123:231–43.
Blankenburg M, Boekens H, Hechler T, Maier C, Krumova E, Scherens A, et al. Reference values for quantitative sensory testing in children and adolescents: developmental and gender differences of somatosensory perception. Pain. 2010;149:76–88.
Wang AK, Gillen DA, Dyck PJ. Effect of simple analgesics on quantitative sensation test threshold. Neurology. 1999;53:1865–7.
Bowsher D, Leijon G, Thuomas KA. Central poststroke pain: correlation of MRI with clinical pain characteristics and sensory abnormalities. Neurology. 1998;51:1352–8.
Freeman R, Chase KP, Risk M. Quantitative sensory testing cannot differentiate simulated sensory loss from sensory neuropathy. Neurology. 2003;60:465–70.
Zaslansky R, Yarnitsky D. Clinical applications of quantitative sensory testing (QST). J Neurol Sci. 1998;153:215–38.
Dyck PJ, O’Brien PC. Quantitative sensory testing in epidemiological and therapeutic studies of peripheral neuropathy. Muscle Nerve. 1999;22:659–62.
Dyck PJ, Karnes JL, O’Brien PC, Litchy WJ, Low PA, Melton 3rd LJ. The Rochester Diabetic Neuropathy Study: reassessment of tests and criteria for diagnosis and staged severity. Neurology. 1992;42:1164–70.
Dyck PJ, Davies JL, Litchy WJ, O’Brien PC. Longitudinal assessment of diabetic polyneuropathy using a composite score in the Rochester Diabetic Neuropathy Study cohort. Neurology. 1997;49:229–39.
Dyck PJ, O’Brien PC, Litchy WJ, Harper CM, Klein CJ, Dyck PJB. Monotonicity of nerve tests in diabetes: subclinical nerve dysfunction precedes diagnosis of polyneuropathy. Diabetes Care. 2005;28(9):2192–200.
Dyck PJ, Dyck PJB, Velosa JA, Larson TS, O’Brien PC. The nerve growth factor study group. Pattern of quantitative sensation testing of hypoesthesia and hyperalgesia are predictive of diabetic polyneuropathy. Diabetes Care. 2000;23:510–7.
Olney R. Clinical trials for polyneuropathy: the role of nerve conduction studies, quantitative sensory testing, and autonomic function testing. J Clin Neurophysiol. 1998;15:129–37.
Apfel SC, Schwartz S, Adornato BT, Freeman R, Biton V, Rendell M, et al. Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy. JAMA. 2000;284:2215–21.
Ametov AS, Barinov A, Dyck PJ, Hermann R, Kozlova N, Litchy WJ, et al. The sensory symptoms of diabetic polyneuropathy are improved with α-lipoic acid: the Sydney trial. Diabetes Care. 2003;26:770–6.
Ziegler D, Low PA, Litchy WJ, Boulton AJ, Vinik AI, Freeman R, et al. Efficacy and safety of antioxidant treatment with α-lipoic acid over 4 years in diabetic polyneuropathy: the Nathan 1 trial. Diabetes Care. 2011;34:2054–60.
Brown MJ, Bird SJ, Watling S, Kaleta H, Hayes L, Eckert S, et al. Natural progression of diabetic neuropathy in the Zenarestat study population. Diabetes Care. 2004;27:1153–9.
Shy M, Frohman EM, So YT, Aresso JC, Cornblath DR, Giuliani MJ, et al. Quantitative sensory testing: report of the therapeutic and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2003;60:898–904.
Bird SJ, Brown MJ, Spino C, Watling S, Foyt HL. Value of repeated measures of nerve conduction and quantitative sensory testing in a diabetic neuropathy trial. Muscle Nerve. 2006;34:214–24.
Lacomis D. Small fiber neuropathy. Muscle Nerve. 2002;26:173–88.
Hoitsma E, Reulen JPH, de Baets M, Drent M, Spaans F, Faber CG. Small fiber neuropathy: a common and important clinical disorder. J Neurol Sci. 2004;227:119–30.
Jamal GA, Hansen S, Weir A, Ballantyne JP. The neurophysiologic investigation of small fiber neuropathies. Muscle Nerve. 1987;10:537–45.
Joint Task Force of the EFNS and the PNS. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. J Peripher Nerv Syst. 2010;15:79–92.
Low V, Sandroni P, Fealey R, Low PA. Detection of small fiber neuropathy by sudomotor testing. Muscle Nerve. 2006;34:57–61.
Periquet MI, Novak V, Collins MP, Nagaraja HN, Erdem S, Nash SM, et al. Painful sensory neuropathy: prospective evaluation using skin biopsy. Neurology. 1999;53:1641–7.
Magda P, Latov N, Renard M, Sander HW. Quantitative sensory testing: high sensitivity in small fiber neuropathy with normal NCS/EMG. J Peripher Nerv Syst. 2002;7:225–8.
Sorensen L, Molyneaux L, Yue DK. The level of small nerve fiber dysfunction does not predict pain in diabetic neuropathy. Clin J Pain. 2006;22:261–5.
Malik RA, Veves A, Walker D, Siddique I, Lye RH, Schady W, et al. Sural nerve pathology in diabetic patients with mild neuropathy: relationship to pain, quantitative sensory testing and peripheral nerve electrophysiology. Acta Neuropathol. 2001;101:367–74.
Baron R, Binder A, Wasner G. Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol. 2010;9:807–19.
Lipton RB, Galer BS, Dutcher JP, Portenoy RK, Berger A, Arezzo JC, et al. Quantitative sensory testing demonstrates that subclinical sensory neuropathy is prevalent in patients with cancer. Arch Neurol. 1987;44:944–6.
Lipton RB, Galer BS, Dutcher JP, Portenoy RK, Pahmer V, Meller F, et al. Large and small fiber type sensory dysfunction in patients with cancer. J Neurol Neurosurg Psychiatry. 1991;54:706–9.
Forsyth PA, Balmaceda C, Peterson K, Seidman AD, Brasher P, DeAngelis LM. Prospective study of paclitaxel-induced peripheral neuropathy with quantitative sensory testing. J Neurooncol. 1997;35:47–53.
Hershman DL, Weimer LH, Wang A, Kranwinkel G, Brafman L, Fuentes L, et al. Association between patient reported outcomes and quantitative sensory tests for measuring long-term neurotoxicity in breast cancer survivors treated with adjuvant paclitaxel chemotherapy. Breast Cancer Res Treat. 2011;125:767–74.
Boyette-Davis JA, Eng C, Wang XS, Cleeland CS, Wendelshafer-Crabb G, Kennedy WR, et al. Subclinical peripheral neuropathy is a common finding in colorectal cancer patients prior to chemotherapy. Clin Cancer Res. 2012;18(12):3180–7.
Chaudhry V, Eisenberger MA, Sinibaldi VJ, Sheikh K, Griffin JW, Cornblath DR. A prospective study of suramin-induced peripheral neuropathy. Brain. 1996;119:2039–52.
Herrmann DN, McDermott MP, Henderson D, Chen L, Akowuah K, Schifitto G, et al. Epidermal nerve fiber density, axonal swellings and QST as predictors of HIV distal sensory neuropathy. Muscle Nerve. 2004;29:420–7.
Herrmann DN, McDermott MP, Sowden JE, Henderson D, Messing S, Cruttenden K, et al. Is skin biopsy a predictor of transition to symptomatic HIV neuropathy? Neurology. 2006;28:857–61.
Evans SR, Clifford DB, Kitch DW, Goodkin K, Schiffito G, McArthur JC, et al. Simplification of the research diagnosis of HIV-associated sensory neuropathy. HIV Clin Trials. 2008;9:434–9.
Berger AR, Arezzo JC, Schaumberg HH, Skowron G, Merigan T, Bozzette S, et al. 2′,3′ -dideoxycytidine (ddC) toxic neuropathy: a study of 52 patients. Neurology. 1993;43:358–62.
Luciano CA, Russell JW, Banerjee TK, Quirk JM, Scott LJ, Dambrosia JM, et al. Physiological characterization of neuropathy in Fabry’s disease. Muscle Nerve. 2002;26:622–9.
Schiffmann R, Floeter MK, Dambrosia JM, Gupta S, Moore DF, Sharabi Y, et al. Enzyme replacement therapy improves peripheral nerve and sweat function in Fabry disease. Muscle Nerve. 2003;28:703–10.
Yosipovitch G, Yarnitsky D, Mermelstein V, Sprecher E, Reiss J, Witenberg C, et al. Paradoxical heat sensation in uremic polyneuropathy. Muscle Nerve. 1995;18:768–71.
Lund C, Koskinen M, Suneetha S, Lockwood DN, Haanpaa M, Haapasalo H, et al. Histopathological and clinical findings in leprosy patients with chronic neuropathic pain: a study from Hyderabad, India. Lepr Rev. 2007;78:369–80.
Hilz MJ, Axelrod FB. Quantitative sensory testing of thermal and vibratory perception in familial dysautonomia. Clin Auton Res. 2000;10:177–83.
Østarvik K, Norheim I, JØrum E. Pain and small-fiber neuropathy in patients with hypothyroidism. Neurology. 2006;67:786–91.
Imai T, Matsumoto H, Minami R. Asymptomatic ulnar neuropathy in carpal tunnel syndrome. Arch Phys Med Rehabil. 1990;71:992–4.
Goadsby PJ, Burke D. Deficits in the function of small and large afferent fibers in confirmed cases of carpal tunnel syndrome. Muscle Nerve. 1994;17:614–22.
Borg K, Lindblom U. Diagnostic value of quantitative sensory testing (QST) in carpal tunnel syndrome. Acta Neurol Scand. 1988;78:537–41.
Merchut MP, Kelly MA, Toleikis SC. Quantitative sensory thresholds in carpal tunnel syndrome. Electromyogr Clin Neurophysiol. 1990;30:119–24.
Werner RA, Franzblau A, Johnston E. Quantitative vibrometry and electrophysiological assessment in screening for carpal tunnel syndrome among industrial workers: a comparison. Arch Phys Med Rehabil. 1994;75:1228–32.
Werner RA, Franzblau A, Johnston E. Comparison of multiple frequency vibrometry testing and sensory nerve conduction measures in screening for carpal tunnel syndrome in an industrial testing. Am J Phys Med Rehabil. 1995;74:101–6.
Zackowski KM, Smith SA, Reich DS, Gordon-Lipkin E, Chodkowski BA, Sambadan DR, et al. Sensorimotor dysfunction in multiple sclerosis and column-specific magnetization transfer-imaging abnormalities in the spinal cord. Brain. 2009;132:1200–9.
Hatem SM, Attal N, Ducreux D, Gautron M, Parker F, Plaghki L, et al. Clinical functional and structural determinants of central pain in syringomyelia. Brain. 2010;133:3409–22.
MacGowan DJ, Janal MN, Clark WC, Wharton RN, Lazar RM, Sacco RL, et al. Central poststroke pain and Wallenberg’s lateral medullary infarction: frequency, character, and determinants in 63 patients. Neurology. 1997;49:120–5.
Gruenwald I, Vardi Y, Gartman I, Juven E, Sprecher E, Yarnitsky D, et al. Sexual dysfunction in females with multiple sclerosis: quantitative sensory testing. Mult Scler. 2007;13:95–105.
Julkunen L, Tenovuo O, Jääskeläinen SK, Hämäläinen H. Recovery of somatosensory deficits in acute stroke. Acta Neurol Scand. 2005;11:366–72.
Acknowledgment
The author wants to thank Ken Maurer, manager of the neurophysiology laboratory at the Nebraska Medical Center, and Debi Kibbee, research assistant at the Department of Neurological Sciences, University of Nebraska Medical Center, for their contribution to all the figures.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Thaisetthawatkul, P. (2014). Quantitative Sensory Testing. In: Katirji, B., Kaminski, H., Ruff, R. (eds) Neuromuscular Disorders in Clinical Practice. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6567-6_11
Download citation
DOI: https://doi.org/10.1007/978-1-4614-6567-6_11
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-6566-9
Online ISBN: 978-1-4614-6567-6
eBook Packages: MedicineMedicine (R0)